0001840574-21-000001.txt : 20210122
0001840574-21-000001.hdr.sgml : 20210122
20210122155851
ACCESSION NUMBER: 0001840574-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210122
DATE AS OF CHANGE: 20210122
EFFECTIVENESS DATE: 20210122
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verve Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840574
IRS NUMBER: 824800132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-387112
FILM NUMBER: 21545740
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (978) 501-3026
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
D
1
primary_doc.xml
X0708
D
LIVE
0001840574
Verve Therapeutics, Inc.
500 TECHNOLOGY SQUARE
CAMBRIDGE
MA
MASSACHUSETTS
02139
(978) 501-3026
DELAWARE
None
None
Corporation
true
2018
Andrew
Ashe
500 Technology Square
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Burt
Adelman
500 Technology Square
Cambridge
MA
MASSACHUSETTS
02139
Director
John
Evans
500 Technology Square
Cambridge
MA
MASSACHUSETTS
02139
Director
Sekar
Kathiresan
500 Technology Square
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Director
Anthony
Philippakis
500 Technology Square
Cambridge
MA
MASSACHUSETTS
02139
Director
Krishna
Yeshwant
500 Technology Square
Cambridge
MA
MASSACHUSETTS
02139
Director
Andrew
Bellinger
500 Technology Square
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2021-01-14
false
true
false
0
93999993
93999993
0
false
22
0
0
0
false
Verve Therapeutics, Inc.
/s/ Andrew Ashe
Andrew Ashe
President and Chief Operating Officer
2021-01-22